In situ photoacoustic spectroscopy of phycobiliproteins in Gracilaria chilensis

peer reviewedPhycobiliproteins, the main polypeptidic components of the phycobilisomes (PBS), are biolog- ical macromolecules arranged in complex interaction systems to perform light harvesting and conduction. The optical properties of these systems can hardly be studied by conventional spectroscopic techniques. Furthermore this techniques also involve laborious chemical extraction methods. Photoacoustic (PA) spec- troscopy was successfully applied to an in situ study of the phycobiliproteins expression in the eukaryotic red algae: Gracilaria chilensis

Spacelike Singularities and Hidden Symmetries of Gravity

We review the intimate connection between (super-)gravity close to a spacelike singularity (the "BKL-limit") and the theory of Lorentzian Kac-Moody algebras. We show that in this limit the gravitational theory can be reformulated in terms of billiard motion in a region of hyperbolic space, revealing that the dynamics is completely determined by a (possibly infinite) sequence of reflections, which are elements of a Lorentzian Coxeter group. Such Coxeter groups are the Weyl groups of infinite-dimensional Kac-Moody algebras, suggesting that these algebras yield symmetries of gravitational theories. Our presentation is aimed to be a self-contained and comprehensive treatment of the subject, with all the relevant mathematical background material introduced and explained in detail. We also review attempts at making the infinite-dimensional symmetries manifest, through the construction of a geodesic sigma model based on a Lorentzian Kac-Moody algebra. An explicit example is provided for the case of the hyperbolic algebra E10, which is conjectured to be an underlying symmetry of M-theory. Illustrations of this conjecture are also discussed in the context of cosmological solutions to eleven-dimensional supergravity.Comment: 228 pages. Typos corrected. References added. Subject index added. Published versio

Higher spin extension of cosmological spacetimes in 3D: asymptotically flat behaviour with chemical potentials and thermodynamics

A generalized set of asymptotic conditions for higher spin gravity without cosmological constant in three spacetime dimensions is constructed. They include the most general temporal components of the gauge fields that manifestly preserve the original asymptotic higher spin extension of the BMS$_{3}$ algebra, with the same central charge. By virtue of a suitable permissible gauge choice, it is shown that this set can be directly recovered as a limit of the boundary conditions that have been recently constructed in the case of negative cosmological constant, whose asymptotic symmetries are spanned by two copies of the centrally-extended W$_{3}$ algebra. Since the generalized asymptotic conditions allow to incorporate chemical potentials conjugated to the higher spin charges, a higher spin extension of locally flat cosmological spacetimes becomes naturally included within the set. It is shown that their thermodynamic properties can be successfully obtained exclusively in terms of gauge fields and the topology of the Euclidean manifold, which is shown to be the one of a solid torus, but with reversed orientation as compared with one of the black holes. It is also worth highlighting that regularity of the fields can be ensured through a procedure that does not require an explicit matrix representation of the entire gauge group. In few words, we show that the temporal components of generalized dreibeins can be consistently gauged away, which partially fixes the chemical potentials, so that the remaining conditions can just be obtained by requiring the holonomy of the generalized spin connection along a thermal circle to be trivial. The extension of the generalized asymptotically flat behaviour to the case of spins $s\geq2$ is also discussed.Comment: 33 pages, one figure. Talk given at the "Meeting on the horizon", Valparaiso, Chile, March 201

Improved functionalization of oleic acid-coated iron oxide nanoparticles for biomedical applications

Superparamagnetic iron oxide nanoparticles can providemultiple benefits for biomedical applications in aqueous environments such asmagnetic separation or magnetic resonance imaging. To increase the colloidal stability and allow subsequent reactions, the introduction of hydrophilic functional groups onto the particles’ surface is essential. During this process, the original coating is exchanged by preferably covalently bonded ligands such as trialkoxysilanes. The duration of the silane exchange reaction, which commonly takes more than 24 h, is an important drawback for this approach. In this paper, we present a novel method, which introduces ultrasonication as an energy source to dramatically accelerate this process, resulting in high-quality waterdispersible nanoparticles around 10 nmin size. To prove the generic character, different functional groups were introduced on the surface including polyethylene glycol chains, carboxylic acid, amine, and thiol groups. Their colloidal stability in various aqueous buffer solutions as well as human plasma and serum was investigated to allow implementation in biomedical and sensing applications.status: publishe

Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes

BACKGROUND: Data are lacking on the long-term effect on cardiovascular events of adding sitagliptin, a dipeptidyl peptidase 4 inhibitor, to usual care in patients with type 2 diabetes and cardiovascular disease. METHODS: In this randomized, double-blind study, we assigned 14,671 patients to add either sitagliptin or placebo to their existing therapy. Open-label use of antihyperglycemic therapy was encouraged as required, aimed at reaching individually appropriate glycemic targets in all patients. To determine whether sitagliptin was noninferior to placebo, we used a relative risk of 1.3 as the marginal upper boundary. The primary cardiovascular outcome was a composite of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for unstable angina. RESULTS: During a median follow-up of 3.0 years, there was a small difference in glycated hemoglobin levels (least-squares mean difference for sitagliptin vs. placebo, -0.29 percentage points; 95% confidence interval [CI], -0.32 to -0.27). Overall, the primary outcome occurred in 839 patients in the sitagliptin group (11.4%; 4.06 per 100 person-years) and 851 patients in the placebo group (11.6%; 4.17 per 100 person-years). Sitagliptin was noninferior to placebo for the primary composite cardiovascular outcome (hazard ratio, 0.98; 95% CI, 0.88 to 1.09; P<0.001). Rates of hospitalization for heart failure did not differ between the two groups (hazard ratio, 1.00; 95% CI, 0.83 to 1.20; P = 0.98). There were no significant between-group differences in rates of acute pancreatitis (P = 0.07) or pancreatic cancer (P = 0.32). CONCLUSIONS: Among patients with type 2 diabetes and established cardiovascular disease, adding sitagliptin to usual care did not appear to increase the risk of major adverse cardiovascular events, hospitalization for heart failure, or other adverse events